헬스케어 블록체인 시장 예측(-2034년) - 구성요소, 블록체인 종류, 도입 형태, 용도, 최종사용자, 지역별 세계 분석

According to Stratistics MRC, the Global Healthcare Blockchain Market is accounted for $1.4 billion in 2026 and is expected to reach $6.8 billion by 2034, growing at a CAGR of 21.7% during the forecast period. Healthcare Blockchain encompasses decentralized distributed ledger technology platforms and solutions applied to healthcare data management, supply chain integrity, clinical research, and financial transaction processing challenges within the medical ecosystem. By recording transactions in immutable, cryptographically secured ledger entries shared across a network of authorized participants, blockchain solutions enable trustworthy data exchange between organizations that lack established bilateral trust relationships.

Market Dynamics:

Driver:

Critical need for secure healthcare data interoperability and patient-centered records

The fragmented nature of global healthcare information systems, where patient data is distributed across incompatible EHR platforms, laboratory systems, pharmacy networks, and imaging repositories, creates significant care coordination gaps that compromise patient safety and clinical efficiency. Blockchain's capacity to enable permissioned data sharing across organizational boundaries without requiring centralized data custodianship is attracting growing interest as a foundation for patient-centered health record architectures. Regulatory mandates for healthcare information exchange, including CMS interoperability rules in the United States and GDPR-compliant cross-border health data sharing frameworks in Europe, are creating institutional incentives to explore blockchain as an enabling technology for trustworthy longitudinal health record access and patient data sovereignty.

Restraint:

Scalability limitations and high energy consumption of blockchain networks

Current public blockchain architectures face fundamental scalability constraints that limit their capacity to handle the transaction throughput volumes required by large-scale healthcare applications. Processing the billions of annual healthcare claims, medication dispensing events, and EHR access transactions within a blockchain environment demands computational resources that existing consensus mechanisms cannot efficiently accommodate. Private and consortium blockchain architectures offer improved performance for enterprise healthcare applications but sacrifice some of the decentralization and immutability benefits that justify blockchain's use over conventional database solutions. Energy consumption concerns associated with proof-of-work consensus mechanisms also raise sustainability questions relevant to healthcare organizations with environmental commitments.

Opportunity:

Pharmaceutical supply chain integrity and drug authentication applications

The pharmaceutical supply chain represents one of the most mature and commercially viable near-term application areas for healthcare blockchain, driven by regulatory requirements for end-to-end drug traceability including the U.S. Drug Supply Chain Security Act and the EU Falsified Medicines Directive. Blockchain platforms enable immutable documentation of drug custody transfers from manufacturer to patient, providing stakeholders with verifiable authenticity records that combat counterfeit medication infiltration. The serialization and verification infrastructure being built to satisfy track-and-trace compliance requirements creates a foundation for blockchain integration that pharmaceutical manufacturers, wholesalers, and pharmacy networks are actively exploring to enhance supply chain visibility and incident response capabilities.

Threat:

Regulatory uncertainty and lack of standardized blockchain governance frameworks

The regulatory classification of blockchain-based healthcare solutions remains ambiguous across most jurisdictions, creating legal uncertainty for organizations developing and deploying these platforms. Questions surrounding data sovereignty in decentralized networks, liability allocation for blockchain-recorded health data, and the application of medical device regulations to smart contract-based healthcare functions have not been definitively resolved by regulators. The absence of standardized governance frameworks for healthcare blockchain consortia, including consensus mechanisms for network participation rules, data access controls, and dispute resolution procedures, creates practical obstacles to multi-organizational blockchain network formation. These regulatory and governance uncertainties are contributing to cautious adoption among risk-averse healthcare enterprises.

Covid-19 Impact:

The COVID-19 pandemic exposed critical vulnerabilities in healthcare supply chains and health data sharing infrastructure that blockchain technology is uniquely positioned to address. PPE and vaccine supply chain disruptions highlighted the value of immutable provenance tracking for critical medical supplies, while fragmented international health data systems complicated pandemic surveillance and cross-border patient care coordination. Several blockchain initiatives for COVID-19 vaccination record verification were implemented across multiple countries, demonstrating practical health data credentialing applications. These pandemic-era use cases have raised awareness of blockchain's healthcare utility among health system executives and government health agencies, providing a foundation for expanded post-pandemic investment in healthcare blockchain infrastructure.

The Solutions segment is expected to be the largest during the forecast period

The Solutions segment is expected to account for the largest market share during the forecast period. Supply chain management solutions, clinical data exchange platforms, identity management tools, and claims processing applications collectively generate the highest revenue contribution, reflecting the commercial priority healthcare organizations place on addressing specific, high-value operational pain points through targeted blockchain deployments. As healthcare organizations gain blockchain implementation experience through initial solution deployments, they are progressively expanding their use of blockchain solutions into adjacent application areas, sustaining strong segment growth. The solutions segment benefits from recurring subscription revenue models that provide predictable income streams for blockchain platform vendors.

The Consortium Blockchain segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the Consortium Blockchain segment is predicted to witness the highest growth rate. Consortium blockchains, governed jointly by a defined group of trusted healthcare organizations including payers, providers, pharmaceutical companies, and regulatory bodies, offer an optimal balance between the decentralization and immutability benefits of public blockchains and the performance and privacy control advantages of private implementations. Healthcare industry consortia developing shared data exchange networks, pharmaceutical track-and-trace ecosystems, and clinical trial data integrity platforms are predominantly adopting consortium blockchain architectures, making this model the most commercially active blockchain type within the healthcare sector.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share. The United States leads global adoption driven by substantial pharmaceutical supply chain compliance mandates, a highly developed health IT investment ecosystem, and active venture capital funding of healthcare blockchain startups. Major U.S. health insurers and pharmacy benefit managers exploring blockchain for claims processing and prior authorization automation represent a significant commercial demand segment. Government initiatives including ONC interoperability regulations and HHS blockchain research programs are also advancing the institutional knowledge base for healthcare blockchain implementation across the American healthcare system.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR. China's national blockchain development strategy includes explicit healthcare applications, and government investment in blockchain-based health record systems and pharmaceutical supply chain platforms is generating growing market activity. India's expanding digital health infrastructure under the Ayushman Bharat Digital Mission is creating integration opportunities for blockchain-based patient identity and health record platforms. Singapore and South Korea are also leading blockchain healthcare innovation through government-industry collaboration programs, making Asia Pacific the most dynamically growing regional market for healthcare blockchain deployment.

Key players in the market

Some of the key players in Global Healthcare Blockchain Market include IBM Corporation, Microsoft Corporation, Oracle Corporation, SAP SE, Guardtime, BurstIQ, Hashed Health, Chronicled Inc., Change Healthcare, Patientory Inc., Solve.Care, Medicalchain SA, iSolve LLC, Factom, and Hewlett Packard.

Key Developments:

In January 2026, IBM Corporation announced the expansion of its IBM Blockchain Platform for healthcare supply chain management, incorporating new serialized drug traceability modules aligned with DSCSA 2026 compliance requirements. The enhanced platform enables pharmaceutical manufacturers and wholesale distributors to achieve end-to-end electronic drug product verification across their supply chains, leveraging IBM's distributed ledger infrastructure to provide immutable custody transfer records accessible to all authorized supply chain participants.

In February 2026, Microsoft Corporation announced a partnership with a consortium of major U.S. health insurers to pilot a blockchain-based prior authorization interoperability network built on Microsoft Azure's distributed ledger services. The pilot aims to demonstrate the feasibility of automating prior authorization decisions through smart contracts that execute against shared eligibility and clinical criteria data, targeting a significant reduction in administrative burden and authorization processing time for both payers and healthcare providers.

Components Covered:

• Platforms
• Solutions
• Services

Blockchain Types Covered:

• Public Blockchain
• Private Blockchain
• Consortium Blockchain
• Hybrid Blockchain

Deployment Modes Covered:

• Cloud-Based
• On-Premises
• Hybrid Deployment

Applications Covered:

• Clinical Data Exchange & Interoperability
• Claims Adjudication and Billing
• Supply Chain Management
• Electronic Health Records (EHR)
• Clinical Trials and Research
• Prescription Drug Management
• Identity and Access Management
• Revenue Cycle Management
• Remote Patient Monitoring
• Healthcare Payments

End Users Covered:

• Healthcare Providers
• Healthcare Payers
• Pharmaceutical & Biotechnology Companies
• Medical Device Companies
• Research Organizations
• Patients and Consumers

Regions Covered:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • United Kingdom
  • Germany
  • France
  • Italy
  • Spain
  • Netherlands
  • Belgium
  • Sweden
  • Switzerland
  • Poland
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Malaysia
  • Singapore
  • Vietnam
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Colombia
  • Chile
  • Peru
  • Rest of South America
• Rest of the World (RoW)
  • Middle East
• Saudi Arabia
• United Arab Emirates
• Qatar
• Israel
• Rest of Middle East
  • Africa
• South Africa
• Egypt
• Morocco
• Rest of Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

• 1.1 Market Snapshot and Key Highlights
• 1.2 Growth Drivers, Challenges, and Opportunities
• 1.3 Competitive Landscape Overview
• 1.4 Strategic Insights and Recommendations

2 Research Framework

• 2.1 Study Objectives and Scope
• 2.2 Stakeholder Analysis
• 2.3 Research Assumptions and Limitations
• 2.4 Research Methodology
  • 2.4.1 Data Collection (Primary and Secondary)
  • 2.4.2 Data Modeling and Estimation Techniques
  • 2.4.3 Data Validation and Triangulation
  • 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

• 3.1 Market Definition and Structure
• 3.2 Key Market Drivers
• 3.3 Market Restraints and Challenges
• 3.4 Growth Opportunities and Investment Hotspots
• 3.5 Industry Threats and Risk Assessment
• 3.6 Technology and Innovation Landscape
• 3.7 Emerging and High-Growth Markets
• 3.8 Regulatory and Policy Environment
• 3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

• 4.1 Porter's Five Forces Analysis
  • 4.1.1 Supplier Bargaining Power
  • 4.1.2 Buyer Bargaining Power
  • 4.1.3 Threat of Substitutes
  • 4.1.4 Threat of New Entrants
  • 4.1.5 Competitive Rivalry
• 4.2 Market Share Analysis of Key Players
• 4.3 Product Benchmarking and Performance Comparison

5 Global Healthcare Blockchain Market, By Component

• 5.1 Platforms
  • 5.1.1 Blockchain infrastructure platforms
  • 5.1.2 Smart contract platforms
  • 5.1.3 Interoperability platforms
• 5.2 Solutions
  • 5.2.1 Identity management solutions
  • 5.2.2 Supply chain management solutions
  • 5.2.3 Clinical data exchange solutions
  • 5.2.4 Claims and billing management solutions
  • 5.2.5 Fraud detection solutions
• 5.3 Services
  • 5.3.1 Consulting services
  • 5.3.2 Integration and deployment services
  • 5.3.3 Support and maintenance services

6 Global Healthcare Blockchain Market, By Blockchain Type

• 6.1 Public Blockchain
• 6.2 Private Blockchain
• 6.3 Consortium Blockchain
• 6.4 Hybrid Blockchain

7 Global Healthcare Blockchain Market, By Deployment Mode

• 7.1 Cloud-Based
• 7.2 On-Premises
• 7.3 Hybrid Deployment

8 Global Healthcare Blockchain Market, By Application

• 8.1 Clinical Data Exchange & Interoperability
• 8.2 Claims Adjudication and Billing
• 8.3 Supply Chain Management
• 8.4 Electronic Health Records (EHR)
• 8.5 Clinical Trials and Research
• 8.6 Prescription Drug Management
• 8.7 Identity and Access Management
• 8.8 Revenue Cycle Management
• 8.9 Remote Patient Monitoring
• 8.10 Healthcare Payments

9 Global Healthcare Blockchain Market, By End User

• 9.1 Healthcare Providers
• 9.2 Healthcare Payers
• 9.3 Pharmaceutical & Biotechnology Companies
• 9.4 Medical Device Companies
• 9.5 Research Organizations
• 9.6 Patients and Consumers

10 Global Healthcare Blockchain Market, By Geography

• 10.1 North America
  • 10.1.1 United States
  • 10.1.2 Canada
  • 10.1.3 Mexico
• 10.2 Europe
  • 10.2.1 United Kingdom
  • 10.2.2 Germany
  • 10.2.3 France
  • 10.2.4 Italy
  • 10.2.5 Spain
  • 10.2.6 Netherlands
  • 10.2.7 Belgium
  • 10.2.8 Sweden
  • 10.2.9 Switzerland
  • 10.2.10 Poland
  • 10.2.11 Rest of Europe
• 10.3 Asia Pacific
  • 10.3.1 China
  • 10.3.2 Japan
  • 10.3.3 India
  • 10.3.4 South Korea
  • 10.3.5 Australia
  • 10.3.6 Indonesia
  • 10.3.7 Thailand
  • 10.3.8 Malaysia
  • 10.3.9 Singapore
  • 10.3.10 Vietnam
  • 10.3.11 Rest of Asia Pacific
• 10.4 South America
  • 10.4.1 Brazil
  • 10.4.2 Argentina
  • 10.4.3 Colombia
  • 10.4.4 Chile
  • 10.4.5 Peru
  • 10.4.6 Rest of South America
• 10.5 Rest of the World (RoW)
  • 10.5.1 Middle East
    • 10.5.1.1 Saudi Arabia
    • 10.5.1.2 United Arab Emirates
    • 10.5.1.3 Qatar
    • 10.5.1.4 Israel
    • 10.5.1.5 Rest of Middle East
  • 10.5.2 Africa
    • 10.5.2.1 South Africa
    • 10.5.2.2 Egypt
    • 10.5.2.3 Morocco
    • 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

• 11.1 Industry Value Network and Supply Chain Assessment
• 11.2 White-Space and Opportunity Mapping
• 11.3 Product Evolution and Market Life Cycle Analysis
• 11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

• 12.1 Mergers and Acquisitions
• 12.2 Partnerships, Alliances, and Joint Ventures
• 12.3 New Product Launches and Certifications
• 12.4 Capacity Expansion and Investments
• 12.5 Other Strategic Initiatives

13 Company Profiles

• 13.1 IBM Corporation
• 13.2 Microsoft Corporation
• 13.3 Oracle Corporation
• 13.4 SAP SE
• 13.5 Guardtime
• 13.6 BurstIQ
• 13.7 Hashed Health
• 13.8 Chronicled Inc.
• 13.9 Change Healthcare
• 13.10 Patientory Inc.
• 13.11 Solve.Care
• 13.12 Medicalchain SA
• 13.13 iSolve LLC
• 13.14 Factom
• 13.15 Hewlett Packard